Philanthropy
Philanthropy is a central aspect of Majid Hamid Jafar’s public life, defined by long-term commitment, institutional collaboration, and measurable impact. His philanthropic efforts are primarily focused on advancing medical research and improving outcomes for underserved patient communities.
In 2015, Majid Jafar and his wife, Lynn Barghout Jafar, co-founded the Loulou Foundation, a non-profit organisation dedicated to advancing scientific research into CDKL5 deficiency disorder. CDKL5 is a rare and severe neurodevelopmental condition that affects children worldwide and has historically received limited research attention.
The foundation supports global research initiatives, funds scientific studies, and convenes researchers and clinicians through the annual CDKL5 Forum. Its work has contributed to increased awareness, improved research coordination, and progress in therapeutic development. In 2020, CDKL5 deficiency disorder was formally recognised as a rare disease within the World Health Organization’s International Classification of Diseases.
Philanthropy is a central aspect of Majid Hamid Jafar’s public life, defined by long-term commitment, institutional collaboration, and measurable impact. His philanthropic efforts are primarily focused on advancing medical research and improving outcomes for underserved patient communities.
In 2015, Majid Jafar and his wife, Lynn Barghout Jafar, co-founded the Loulou Foundation, a non-profit organisation dedicated to advancing scientific research into CDKL5 deficiency disorder. CDKL5 is a rare and severe neurodevelopmental condition that affects children worldwide and has historically received limited research attention.
The foundation supports global research initiatives, funds scientific studies, and convenes researchers and clinicians through the annual CDKL5 Forum. Its work has contributed to increased awareness, improved research coordination, and progress in therapeutic development. In 2020, CDKL5 deficiency disorder was formally recognised as a rare disease within the World Health Organization’s International Classification of Diseases.
Majid Jafar also serves on the Board of Fellows of Harvard Medical School, supporting one of the world’s leading institutions in medical education and research. This role reflects a broader commitment to advancing scientific excellence and healthcare innovation.
His philanthropic approach prioritises sustained engagement over short-term initiatives, focusing on areas where long-term support can drive meaningful change. In addition to medical research, he and his family support cultural and educational initiatives, including the Dubai Collection for Art.
Through philanthropy, Majid Jafar seeks to contribute beyond business, addressing challenges that require patience, collaboration, and long-term vision.
Majid Jafar also serves on the Board of Fellows of Harvard Medical School, supporting one of the world’s leading institutions in medical education and research. This role reflects a broader commitment to advancing scientific excellence and healthcare innovation.
His philanthropic approach prioritises sustained engagement over short-term initiatives, focusing on areas where long-term support can drive meaningful change. In addition to medical research, he and his family support cultural and educational initiatives, including the Dubai Collection for Art.
Through philanthropy, Majid Jafar seeks to contribute beyond business, addressing challenges that require patience, collaboration, and long-term vision.